Indications
Active immunisation against smallpox, monkeypox and disease caused by vaccinia virus in individuals 12 years of age and older (see sections 4.4 and 5.1).The use of this vaccine should be in accordance with official recommendations.
Composition
- Active substance
- modified vaccinia Ankara - Bavarian Nordic (MVA-BN) virus
- International name (INN)
- smallpox and monkeypox vaccine (Live Modified Vaccinia Virus Ankara)
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Imvanex
- Active substance
- modified vaccinia Ankara - Bavarian Nordic (MVA-BN) virus
- ATC code
- J07BX
- Therapeutic area